Advertisement

Related Videos

Varsha Gandhi, PhD, on Ibrutinib

Opening Session Panel Discussion

Opportunities to Optimize Cancer Policies Panel Discussion

CS Pramesh, MS, FRCS, on Opportunities in India: A Perspective From a Low-Middle Income Country

Peter Clark, MA, MD, FRCP: A Payer Perspective

Advertisement

Advertisement




Apr
01
Today In Oncology
Activity Observed With Novel KRAS Inhibitor in Pancreatic Cancer (1)
Early Results From a Trial of Active Surveillance for Low-Risk DCIS Are Reassuring Say Researchers
AI-Driven Multiagent System for Guiding First-Line Immunotherapy for NSCLC
Machine-Learning Model for HCC Risk Prediction May Outperform Current Methods
Nivolumab With or Without Ipilimumab in Platinum-Refractory Advanced Neuroendocrine Carcinoma
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo